🇺🇸 FDA
Patent

US 12109224

USB1 directed regulation of miRNAs related hematopoietic differentiation and affected in multiple forms of leukemia

granted A61KA61K31/4375A61K31/713

Quick answer

US patent 12109224 (USB1 directed regulation of miRNAs related hematopoietic differentiation and affected in multiple forms of leukemia) held by The Regents of the University of Colorado, a Body Corporate expires Mon Oct 03 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of Colorado, a Body Corporate
Grant date
Tue Oct 08 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 03 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
2
CPC classes
A61K, A61K31/4375, A61K31/713